(Q43265620)

17 November 2017

title

Role of clobazam in the treatment of epilepsies (English)

1 reference

17 November 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

31413

author name string

Maria Augusta Montenegro

series ordinal

1

1 reference

17 November 2017

Carlos A M Guerreiro

series ordinal

2

1 reference

17 November 2017

publication date

1 November 2003

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 November 2017

published in

1 reference

17 November 2017

volume

3

1 reference

17 November 2017

issue

6

1 reference

17 November 2017

page(s)

829-834

1 reference

Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

The long-term effect of clobazam as adjunctive therapy in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

The effects of benzodiazepine use during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Tolerance to the anticonvulsant effects of clobazam in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Use of clobazam for the treatment of refractory complex partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A Retrospecti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.6.829

21 January 2018

Identifiers

DOI

10.1586/14737175.3.6.829

1 reference

17 November 2017

1 reference